37
Participants
Start Date
February 29, 2012
Primary Completion Date
April 30, 2016
Study Completion Date
April 30, 2016
Dynamic Contrast-Enhanced Magnetic Resonance Imaging
Correlative studies
Laboratory Biomarker Analysis
Correlative studies
Pharmacological Study
Correlative studies
Trebananib
Given IV
Columbia University/Herbert Irving Cancer Center, New York
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Childrens Oncology Group, Philadelphia
Children's National Medical Center, Washington D.C.
Children's Healthcare of Atlanta - Egleston, Atlanta
Children's Hospital of Alabama, Birmingham
University of Alabama at Birmingham Cancer Center, Birmingham
St. Jude Children's Research Hospital, Memphis
Cincinnati Children's Hospital Medical Center, Cincinnati
Riley Hospital for Children, Indianapolis
C S Mott Children's Hospital, Ann Arbor
Children¿s Hospital of Wisconsin, Milwaukee
University of Minnesota/Masonic Cancer Center, Minneapolis
Lurie Children's Hospital-Chicago, Chicago
Washington University School of Medicine, St Louis
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Children's Hospital of Orange County, Orange
UCSF Medical Center-Parnassus, San Francisco
Oregon Health and Science University, Portland
Seattle Children's Hospital, Seattle
Hospital for Sick Children, Toronto
National Cancer Institute (NCI)
NIH